pISSN 1226-6051
eISSN 2508-786X

Table. 3.

Table. 3.

Sleep assessment effect sizes for the comparison of pre-treatment and post-treatment

Assessment Group 1 Group 2 Group 3

ES 95% CI p-value ES 95% CI p-value ES 95% CI p-value
① ISI Intervention 1.58 0.70, 2.46 0.0004 1.63 1.48, 1.79 <0.00001 1.46 1.16, 1.77 <0.00001
Control 2.13 1.69, 2.57 <0.00001 0.71 0.57, 0.85 <0.00001 0.38 0.22, 0.53 <0.00001
② PSQI Intervention 0.81 0.48, 1.14 <0.00001 1.02 0.78, 1.25 <0.00001 0.9 0.61, 1.19 <0.00001
Control 0.76 0.45, 1.07 <0.00001 0.18 -0.05, 0.40 0.12 0.09 -0.08, 0.26 0.29
③ SE Intervention -0.61 -1.16, -0.05 0.03 -1.09 -1.28, -0.90 <0.00001 -0.73 -0.91, -0.56 <0.00001
Control -0.77 -1.38, -0.16 0.01 -0.55 -0.73, -0.38 <0.00001 -0.20 -0.31, -0.10 0.0002
④ TST Intervention -0.36 -0.80, 0.09 0.11 -0.44 -0.53, -0.35 <0.00001 -0.44 -0.56, -0.31 <0.00001
Control -0.39 -0.79, 0.02 0.06 -0.38 -0.49, -0.27 <0.00001 -0.15 -0.24, -0.06 0.001
⑤ WASO Intervention 0.42 0.15, 0.70 0.002 0.92 0.80, 1.03 <0.00001 0.48 0.25, 0.70 <0.0001
Control 0.71 0.18, 1.24 0.008 0.37 0.23, 0.51 <0.00001 0.17 0.03, 0.30 0.01

Note. ISI=Insomnia Severity Index; PSQI=Pittsburgh Sleep Quality Index; SE=Sleep Efficiency; TST=Total Sleep Time; WASO=Wake Time After Sleep Onset

Korean J Clin Pharm 2023;33:221-41 https://doi.org/10.24304/kjcp.2023.33.4.221
© 2023 Korean J Clin Pharm